John Abramson

656 total citations
19 papers, 416 citations indexed

About

John Abramson is a scholar working on Surgery, Economics and Econometrics and Pharmacology. According to data from OpenAlex, John Abramson has authored 19 papers receiving a total of 416 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 8 papers in Economics and Econometrics and 5 papers in Pharmacology. Recurrent topics in John Abramson's work include Health Systems, Economic Evaluations, Quality of Life (6 papers), Lipoproteins and Cardiovascular Health (6 papers) and Pharmaceutical industry and healthcare (5 papers). John Abramson is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (6 papers), Lipoproteins and Cardiovascular Health (6 papers) and Pharmaceutical industry and healthcare (5 papers). John Abramson collaborates with scholars based in United States, Canada and Denmark. John Abramson's co-authors include James M Wright, H Rosenberg, Marc A. Rodwin, Franz Goldstein, Matthew J. Budoff, A. Abraham, J. Douglas Thornton, Tomohito Hamazaki, Harumi Okuyama and Hyman Menduke and has published in prestigious journals such as The Lancet, JAMA and Gastroenterology.

In The Last Decade

John Abramson

17 papers receiving 384 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Abramson United States 9 192 163 74 74 70 19 416
Hubertus G. M. Leufkens Netherlands 17 182 0.9× 258 1.6× 51 0.7× 61 0.8× 48 0.7× 30 731
Laney K. Jones United States 15 239 1.2× 326 2.0× 77 1.0× 23 0.3× 124 1.8× 60 668
Gisbert Selke Germany 10 202 1.1× 127 0.8× 46 0.6× 44 0.6× 19 0.3× 20 765
Brita Pekarsky Australia 12 138 0.7× 57 0.3× 105 1.4× 34 0.5× 55 0.8× 31 389
Cheryl Fahlman United States 9 149 0.8× 67 0.4× 133 1.8× 16 0.2× 35 0.5× 16 396
Karen Van Nuys United States 10 128 0.7× 47 0.3× 56 0.8× 26 0.4× 45 0.6× 24 590
Lukas G. Keil United States 9 141 0.7× 95 0.6× 67 0.9× 49 0.7× 190 2.7× 15 533
Waqas Haque United States 10 66 0.3× 65 0.4× 50 0.7× 36 0.5× 51 0.7× 32 288
Jyotsna Mehta United States 11 277 1.4× 29 0.2× 26 0.4× 112 1.5× 67 1.0× 25 712
Amarnath Annapureddy United States 11 137 0.7× 31 0.2× 117 1.6× 77 1.0× 47 0.7× 23 446

Countries citing papers authored by John Abramson

Since Specialization
Citations

This map shows the geographic impact of John Abramson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Abramson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Abramson more than expected).

Fields of papers citing papers by John Abramson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Abramson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Abramson. The network helps show where John Abramson may publish in the future.

Co-authorship network of co-authors of John Abramson

This figure shows the co-authorship network connecting the top 25 collaborators of John Abramson. A scholar is included among the top collaborators of John Abramson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Abramson. John Abramson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Demasi, Maryanne, Rita F. Redberg, & John Abramson. (2025). Statins for Primary Prevention of Cardiovascular Disease. JAMA. 333(10). 908–908.
2.
Abramson, John. (2019). What will the Cochrane brand stand for?. Indian Journal of Medical Ethics. 4(3). 245–247. 2 indexed citations
3.
Abramson, John. (2017). Statins in Persons at Low Risk of Cardiovascular Disease.. PubMed. 96(9). Online–Online. 2 indexed citations
4.
Malhotra, Aseem, et al.. (2016). More clarity needed on the true benefits and risks of statins. Prescriber. 27(12). 15–17. 1 indexed citations
5.
6.
Abramson, John, et al.. (2013). Should people at low risk of cardiovascular disease take a statin?. BMJ. 347(oct22 3). f6123–f6123. 138 indexed citations
7.
Rodwin, Marc A. & John Abramson. (2012). Clinical Trial Data as a Public Good. JAMA. 308(9). 871–871. 31 indexed citations
8.
Lorgeril, Michel de, Patricia Salen, John Abramson, et al.. (2010). Cholesterol Lowering, Cardiovascular Diseases, and the Rosuvastatin-JUPITER Controversy. 10 indexed citations
9.
Abramson, John, et al.. (2007). Are lipid-lowering guidelines evidence-based?. The Lancet. 369(9557). 168–169. 72 indexed citations
10.
Wright, James M & John Abramson. (2007). Statins for primary prevention of coronary artery disease – Authors' reply. The Lancet. 369(9567). 1079–1079. 2 indexed citations
11.
Abramson, John, et al.. (2005). When Health Policy Is the Problem: A Report from the Field. Journal of Health Politics Policy and Law. 30(3). 327–366. 12 indexed citations
12.
Abramson, John. (2004). Overdosed America: The Broken Promise of American Medicine. 78 indexed citations
13.
Goldstein, Franz, et al.. (1987). Favorable effects of sulfasalazine on small bowel Crohn's disease: a long-term study.. PubMed. 82(9). 848–53. 15 indexed citations
14.
Abramson, John, et al.. (1987). Competition, Capitation, and Case Management: Barriers to Strategic Reform. Milbank Quarterly. 65(3). 348–348. 19 indexed citations
15.
Budoff, Matthew J., et al.. (1981). Due Process Hearings: Appeals for Appropriate Public School Programs. Exceptional Children. 48(2). 180–182. 8 indexed citations
16.
Goldstein, Franz, Hyman Menduke, J. Douglas Thornton, & John Abramson. (1980). Anti-inflammatory Drug Treatment of Crohnʼs Disease. Journal of Clinical Gastroenterology. 2(1). 77–86. 3 indexed citations
17.
Goldstein, Franz, et al.. (1980). Acute and relapsing pancreatitis caused by bile pigment aggregates and diagnosed by biliary drainage.. PubMed. 74(3). 225–30. 14 indexed citations
18.
Goldstein, Franz, et al.. (1976). Anti-inflammatory drug treatment in Crohn's disease.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 66(3). 251–8. 2 indexed citations
19.
Goldstein, Franz, A. Abraham, John Abramson, & J. Douglas Thornton. (1976). Ileojejunitis in a Pair of Identical Twins. Gastroenterology. 71(4). 670–674. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hubertus G. M. Leufkens Breakdown of academic impact, for papers by Laney K. Jones Breakdown of academic impact, for papers by Gisbert Selke Breakdown of academic impact, for papers by Brita Pekarsky Breakdown of academic impact, for papers by Cheryl Fahlman Breakdown of academic impact, for papers by Karen Van Nuys Breakdown of academic impact, for papers by Lukas G. Keil Breakdown of academic impact, for papers by Waqas Haque Breakdown of academic impact, for papers by Jyotsna Mehta Breakdown of academic impact, for papers by Amarnath Annapureddy
Rankless by CCL
2026